Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.

Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):387-92. Review.

PMID:
15225806
2.

Vitamin D regulation of the renin-angiotensin system.

Li YC.

J Cell Biochem. 2003 Feb 1;88(2):327-31. Review.

PMID:
12520534
3.

[Vitamin D and hypertension, is there a link?].

Phan O, Burnier M.

Rev Med Suisse. 2007 Sep 12;3(124):2022-4, 2026. Review. French.

PMID:
17955830
4.
5.

[Vitamin D and endocrine diseases].

Schuch NJ, Garcia VC, Martini LA.

Arq Bras Endocrinol Metabol. 2009 Jul;53(5):625-33. Review. Portuguese.

6.

AT(1) receptors and control of blood pressure: the kidney and more...

Crowley SD, Gurley SB, Coffman TM.

Trends Cardiovasc Med. 2007 Jan;17(1):30-4. Review.

PMID:
17210476
7.

Vitamin D resistance.

Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G.

Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):627-45. Review.

PMID:
17161336
8.

A local pancreatic renin-angiotensin system: endocrine and exocrine roles.

Leung PS, Chappell MC.

Int J Biochem Cell Biol. 2003 Jun;35(6):838-46. Review.

PMID:
12676170
9.

The renin-angiotensin system. New concepts in regulation of blood pressure and renal function.

Goldfarb DA.

Urol Clin North Am. 1994 May;21(2):187-94. Review.

PMID:
8178386
10.

Vitamin D action : Lessons learned from genetic mouse models.

Goltzman D.

Ann N Y Acad Sci. 2010 Mar;1192:145-52. doi: 10.1111/j.1749-6632.2009.05226.x. Review.

PMID:
20392230
11.

Inhibition of renin: an updated review of the development of renin inhibitors.

Li YC.

Curr Opin Investig Drugs. 2007 Sep;8(9):750-7. Review.

PMID:
17729187
12.

Vitamin D biology in heart failure: molecular mechanisms and systematic review.

Meems LM, van der Harst P, van Gilst WH, de Boer RA.

Curr Drug Targets. 2011 Jan;12(1):29-41. Review.

PMID:
20795939
13.
14.
15.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
16.

Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.

Dietze GJ, Henriksen EJ.

J Renin Angiotensin Aldosterone Syst. 2008 Jun;9(2):75-88. doi: 10.3317/jraas.2008.011. Review.

PMID:
18584583
17.

Vitamin D analogs: novel therapeutic agents for cardiovascular disease?

Reinhart GA.

Curr Opin Investig Drugs. 2004 Sep;5(9):947-51. Review.

PMID:
15503649
18.

Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.

Kurdi M, De Mello WC, Booz GW.

Int J Biochem Cell Biol. 2005 Jul;37(7):1357-67. Review.

PMID:
15833268
19.

Vitamin D action: lessons learned from hereditary 1,25-dihydroxyvitamin-D-resistant rickets patients.

Tiosano D, Gepstein V.

Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):452-9. doi: 10.1097/MED.0b013e32835a3415. Review.

PMID:
23128575
20.

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

Cantorna MT, Zhu Y, Froicu M, Wittke A.

Am J Clin Nutr. 2004 Dec;80(6 Suppl):1717S-20S. Review.

Supplemental Content

Support Center